Patents by Inventor Anne BRISSET

Anne BRISSET has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification of anticoagulants in a sample
    Patent number: 11846640
    Abstract: The present invention is directed to a novel method of determining inhibitors of proteolytically active coagulation factors, referred to herein as anticoagulants, in a sample, in particular the qualitative detection of direct thrombin and factor Xa inhibitors in a sample. The method of the present invention allows a qualitative determination of the nature anticoagulants present in a sample. This can be achieved with only one coagulation-based test. The method can be used in a test kit, including a point-of-care (POC) system.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: December 19, 2023
    Assignee: PENTAPHARM AG
    Inventors: Abel Ferrandez, Anne Brisset
  • IDENTIFICATION OF ANTICOAGULANTS IN A SAMPLE
    Publication number: 20190302132
    Abstract: The present invention is directed to a novel method of determining inhibitors of proteolytically active coagulation factors, referred to herein as anticoagulants, in a sample, in particular the qualitative detection of direct thrombin and factor Xa inhibitors in a sample. The method of the present invention allows a qualitative determination of the nature anticoagulants present in a sample. This can be achieved with only one coagulation-based test. The method can be used in a test kit, including a point-of-care (POC) system.
    Type: Application
    Filed: April 9, 2019
    Publication date: October 3, 2019
    Inventors: Abel FERRANDEZ, Anne BRISSET
  • IDENTIFICATION OF ANTICOAGULANTS IN A SAMPLE
    Publication number: 20160305966
    Abstract: The present invention is directed to a novel method of determining inhibitors of proteolytically active coagulation factors, referred to herein as anticoagulants, in a sample, in particular the qualitative detection of direct thrombin and factor Xa inhibitors in a sample. The method of the present invention allows a qualitative determination of the nature anticoagulants present in a sample. This can be achieved with only one coagulation-based test. The method can be used in a test kit, including a point-of-care system.
    Type: Application
    Filed: December 9, 2014
    Publication date: October 20, 2016
    Inventors: Abel FERRANDEZ, Anne BRISSET